Abstract
Introduction 63
Diabetes is the most prevalent metabolic disorder in the US and is projected to increase 64 by 3-fold by the year 2050 (Boyle et al., 2010) . Approximately 50-70% of diabetic patients 65 exhibit diabetic neuropathy (DN), which first emerges in the hands and feet as distal nerve fibers 66 degenerate in a "glove and stocking pattern" (Harati, 2007) . Patients may experience painful 67 burning and tingling sensations, but all gradually lose normal touch and temperature sensation, 68 leading to accidental personal injuries and impaired quality of life. Despite the prevalence and 69 severe sequelae of DN, the biological mechanisms underlying this devastating disorder remain 70 elusive (Zochodne, 1996; Feldman et al., 1999) . Hyperglycemia has been identified as the 71 fundamental metabolic disturbance; however, the relationship between early metabolic events, 72 vascular damage and structural and functional changes in nerves is unclear. Although 73 controlling blood glucose and glycated hemoglobin (HbA 1C ) levels with insulin remains the most 74 effective method to prevent DN, this approach fails for many patients as it only reduces the 75 incidence of DN by 34% over a 9 year period (DCCT Research Group., 1993) . Also, insulin 76 treatment does little for the 7% of patients who already exhibit neuropathy when diagnosed with 77 diabetes (Pirart, 1977) . Tricyclic antidepressants, duloxetine, gabapentin, aldose-reductase 78 inhibitors, α-lipoic acid, and antioxidants demonstrate mixed efficacy in treating DN and 79 practitioners cannot predict the medication(s) that will aid a given patient (Fedele and Giugliano, 80 1997; Ziegler, 2009) . The combination of both painful symptoms and sensory loss caused by DN 81 further complicates treatment. 82
From a morphological standpoint, chronic diabetes leads to the degeneration and 83 regeneration of peripheral axons (Greene et al., 1999) . Complicating this process, diabetes 84 attenuates the expression of genes that are important in axon regeneration such as neurofilament, 85 8 adapted slowly were classified as A-mechanoreceptor (AM) fibers. As previously reported, D-162 hair fibers had large receptive fields (4-8 mm) and were sensitive to very low mechanical forces 163 (<1.0 mN; Stucky et. al., 1998) . For AM and C fibers, after mechanical stimuli, thermal and 164 chemical stimuli were applied as follows.. Receptive fields were superfused with heated buffer, 165 increasing the temperature from 32°C to 52°C over 10 sec. Subsequently, a 2 min baseline was 166 recorded followed by the application of 1 µM capsaicin for 2 min (Lennertz et al., 2010) . The 167 heat response threshold and number of action potentials elicited by heat or capsaicin were 168 quantified. All stimulus traces were collected via a Powerlab/4sp multichannel recorder and 169 analyzed via Chart software (AD Instruments). 170
171
Microscopy: Samples for microscopy consisted of four STZ-treated mice and four nondiabetic 172 controls. Eight weeks after injection with STZ, animals were killed under anesthesia. The 173 saphenous nerve (proximal nerve samples) and skin from the dorsal hindpaw (distal nerve 174 samples) were exposed and incubated in primary fixative in-situ (4% glutaraldehyde/ 1x PBS pH 175 7.4; 5 min). Samples were dissected, immersion fixed at 4 °C for 1.5 days, post fixed with 1% 176 osmium tetroxide + 1.5% potassium ferricyanide/PBS 2 hrs., dehydrated in ethanol and 177 propylene oxide, and embedded in epon araldite resin which was then polymerized at 60 °C 178 overnight. Semithin sections (0.5 µm) were cut using a RMC Powertome XL, post-stained with 179 toluidine blue, and examined using a Nikon Eclipse light microscope. Light micrographs of 180 entire nerve bundles were analyzed for morphology and axon count. In distal sections, this 181 included sub-dermal nerve bundles surrounded by a perineurial sheath. Ultrathin sections for 182 electron microscopy were cut on a Reichert Ultracut E, post-stained with uranyl acetate and lead 183 citrate, and examined on a JEOL 100CX transmission electron microscope. At least 3 high power 184 fields were selected at random from the proximal and distal nerve segments of each animal. 185
Axon area, axon perimeter and myelin thickness were measured using ImageJ 1.43 software. 186
Separations between the axoplasm and myelin sheath were counted as "axon-myelin separations" 187 when the area of the separation exceeded 6% of the total cross-sectional area of the axon. 188
189
Statistical analyses: For normally distributed data, the mean ± standard deviation were 190 calculated and comparisons were made between 2 groups using a Student's t-test, or across 191 multiple measurements between 2 groups using a two-way ANOVA followed by Bonferroni 192 post-hoc test (*). For non-normally distributed data, the median ± interquartile range were 193 calculated, and comparisons were made between 2 groups using a Wilcoxon rank-sum test, 194 whereas comparisons between ≥3 groups were made using a Kruskal-Wallace test followed by a 195 post-hoc Dunn's multiple comparison test among selected groups ( †). Analyses between 2 196
proportions were made using a Fisher's exact test, and between ≥3 proportions were made using 197 a Chi-square test followed by the standardized residual method to compare the contributions of 198 individual proportions ( ‡). Comparisons between sample locations were made using a Haenszel test of homogeneity ( §). 200
201

Results
202
Diabetic C57Bl/6 mice develop mechanical and thermal hypoalgesia 203 Eight weeks after STZ injection, the serum glucose of diabetic mice was elevated from 204 151±7 in control mice to an average of 521±16 mg/dL (p < .01; Fig 1A) . Whereas non-diabetic 205 controls weighed an average of 28±1 grams, diabetic mice weighed only 17±1 grams on average 206 (p < .01; Fig 1B) . Behavioral mechanical threshold and thermal response latency were also 207 measured at this time. Diabetic mice displayed markedly increased mechanical thresholds 208 compared to nondiabetic mice (median of 20 mN vs 6.8 mN respectively, p < .01; Fig 1C) . 209 Diabetic mice also displayed significantly longer withdraw latencies to a noxious heat stimulus 210 compared to nondiabetic animals (17±1 sec vs 9±1 sec respectively, p < .01; Fig 1D) . Thus, 211
C57Bl/6 diabetic mice exhibit hypoalgesia to both mechanical and heat stimuli. 212
213
Nerves from diabetic mice have nearly normal morphology in semithin sections 214 Next, we determined whether diabetes induces nerve fiber loss, demyelination or changes 215 in axon morphology by using light microscopy. Samples were taken from the saphenous nerve 216 trunk above the knee joint (proximal nerve) and at the level of the hindpaw from small fascicles 217 coursing beneath the dermis in the hindpaw (distal nerve). Proximal nerve semithin sections 218 from nondiabetic mice displayed normal morphology. Myelinated nerve fibers appeared mostly 219 round and without pronounced compression, as can be caused by the hypertonic fixative 220 solutions used to fix peripheral nerves (Fig 2A, top left) . Excluding fibers near an internode 221 which naturally appear crenellated, myelinated nerve fibers appeared slightly less round in 222 proximal nerve semithin sections from diabetic mice. While this appearance could have been 223 caused by high blood glucose levels in diabetic mice, we can not rule out the possibility that 224 diabetic tissue responded differently than nondiabetic tissue to our fixative solution. Otherwise, 225 proximal nerve segments from diabetic mice exhibited normal myelination and morphology (Fig  226   2A, top right) . Further, counts of myelinated axons in the proximal nerve trunk did not reveal 227 any nerve fiber loss from diabetic saphenous nerves (Fig 2B) . 228
Similarly, distal nerve semithin sections from both nondiabetic and diabetic mice 229 exhibited mostly normal structure (Fig 2A, bottom left, bottom right) . In particular, distal nerve 230 sections from diabetic animals did not exhibit demyelination, axonal degeneration or atrophy. 231
Counts of myelinated axons did not reveal a loss of nerve fibers from distal nerve fascicles in 232 diabetic mice (Fig 2C) . However, unmyelinated axons from diabetic mice consistently appeared 233 more intensely stained by toludine blue. Also, separations between the axon and myelin sheath 234 were noticeable in many myelinated nerve fibers in diabetic nerve fascicles (Fig 2A, bottom  235 right; highlighted by arrows). 236
237
Electron micrographs reveal altered morphology in distal diabetic nerves 238
Changes in the morphology of diabetic nerves became increasingly noticeable in higher-239 magnification electron micrographs of distal nerve segments. Nondiabetic axons exhibit a fine, 240 lightly-stained filament network in the axoplasm with some more darkly stained microtubules 241 and few mitochondria (Fig 3A, arrows) . In comparison, the axoplasm of diabetic axons appears 242 quite dense in neurofilaments and contains numerous mitochondria (Fig 3B, arrows) . The left 243 axon in Fig 3B displays a small amount of Schwann cell cytoplasm at the axon-myelin junction 244 (arrowheads). The right axon in Fig 3B shows increasing separation between the axoplasm and 245 myelin, with a larger amount of Schwann cell cytoplasm and a partially extracted area. In many 246 axons, this space became progressively larger near the internode (Supplemental Fig 2) . It was 247 noted that the density of axoplasm components was greater near the internode in both 248 nondiabetic and diabetic axons, but nonetheless the density of the axoplasm appeared more 249 dense in diabetic axons than in nondiabetic axons. Although the axoplasm appeared to be more 250 dense in diabetic axons, there was no difference in the cross sectional area of myelinated 251 nondiabetic axons compared diabetic axons (Supplemental Fig 1A) . 252
Unmyelinated axons from diabetic mice stained more intensely than unmyelinated axons 253 from nondiabetic mice (Fig 4A, arrowheads) . This made individual components of the axoplasm 254
in unmyelinated axons more difficult to discern in diabetic mice. This effect was not due to a 255 decrease in the size of unmyelinated axons. Rather, unmyelinated axons were slightly larger in 256 proximal nerve segments from diabetic mice (p<0.001, Supplemental Fig 1B) . However, as the 257 size distribution of unmyelinated axons overlaps almost completely between nondiabetic and 258 diabetic samples, it is not clear that this represents a meaningful change in the caliber of 259 unmyelinated axons. 260
Separations between the axoplasm and the myelin sheath were prevalent in distal diabetic 261 nerves, occurring in 47% of myelinated axons and contained varying amounts of material in the 262 developing space (Fig 4A, lower panel, arrows) . In comparison, separations between the axon 263 and myelin sheath were smaller in size and were present in only 10% of distal nondiabetic nerve 264 axons (p < 0.001; Fig 4B) . Axon-myelin separations were also infrequent in the proximal 265 segments of nondiabetic and diabetic nerves (5% and 8%, respectively). Thus, axon-myelin 266 separations were restricted to distal segments of diabetic nerves (p < 0.05, Fig 4B) . 267
In addition, we examined distal myelinated axons according to their size distribution 268 (μm 2 ). Since Aβ fiber axons are generally larger than Aδ fiber axons, we reasoned that the upper 269 quartile of the distribution would contain mostly Aβ fiber axons and the lower quartile would 270 contain mostly Aδ fiber axons. In diabetic mice, the frequency of axon-myelin separations was 271 strikingly high (66%) among axons in the upper quartile compared to axons in the lower quartile 272 of the size distribution (17%, p<0.001, Fig 4C, right) . In contrast, the frequency of these changes 273 did not change between the upper and lower quartiles in nondiabetic mice (16% and 10% 274 respectively, Fig 4C, left) . These data suggest that Aβ fiber axons exhibit axon-myelin 275 separations more frequently than Aδ fiber axons in diabetic mice. These morphological findings 276 support electrophysiological data (see below) indicating that Aβ myelinated fibers are 277 particularly affected during diabetes in C57Bl/6 mice ( Fig 5) . 278
279
Diabetic mice lose functional Aβ fiber innervation 280
To examine functional cutaneous innervation, diabetic and nondiabetic mice were 281 sacrificed for ex-vivo teased fiber recordings from the hindpaw skin 1-2 days after the behavioral 282 measurements were made. Mechanical search stimuli were used to identify isolated receptive 283 fields of nerve fibers. Each fiber encountered was characterized according to its conduction 284 velocity and mechanical adaptation. Aβ fibers (> 10 m/s) accounted for 44% of all nerve fibers 285 classified from nondiabetic skin, but only 21% of nerve fibers classified from diabetic skin (p < 286 .001; Fig 5A) . A reciprocal trend was observed in the prevalence of Aδ fibers and C fibers, as 287 would be the expected result of a relative loss of Aβ fibers (1.2 to 10 m/s and less than 1.2 m/s, 288 respectively). No changes were observed in the ratio of Rapidly Adapting versus Slowly 289
Adapting Aβ fibers in diabetic versus nondiabetic preparations (Fig 5B) . Similarly, no 290 significant changes were observed in the ratio of rapidly adapting Aδ (D hair) versus slowly 291 adapting Aδ (AM) fibers (Fig 5C) . The loss in Aβ fibers is consistent with the observed increase 292 in behavioral mechanical thresholds among diabetic mice, as Slowly-Adapting Aβ and Rapidly-293
Adapting Aβ fibers mediate light touch sensation. 294 295 C fiber mechanical responses are markedly impaired in diabetic mice 296
Although we observed few examples of overt axon degeneration, the majority of axons in 297 the diabetic nerve fascicles exhibited separations from the myelin sheath and a density of 298 axoplasm components that may indicate compromised axon function. Therefore, we tested the 299 mechanical threshold and suprathreshold responsiveness of individual nerve fibers. Mechanical 300 thresholds were assessed by applying calibrated von Frey filaments to the cutaneous receptive 301 field of nerve fibers in the skin-nerve preparation. There was a nonsignificant trend toward 302 increased mechanical thresholds in C fibers from diabetic mice (p = 0.08, Table 1 ). However, no 303 significant differences were detected in mechanical thresholds among the subtypes of nerve 304 fibers in diabetic and nondiabetic mice (Table 1) . 305
Subsequently, we assessed the mechanical responsiveness of nerve fibers to 306 suprathreshold force. Increasing mechanical forces between 5 and 200 mN were applied to 307 individual receptive fields and the number of action potentials elicited at each force was 308 compared between diabetic and nondiabetic mice. Diabetes had the greatest effect on 309 unmyelinated C fibers. C fibers from diabetic mice exhibited tepid action potential firing to 310 mechanical stimuli at forces greater than 20 mN (p < 0.01, Fig 6A) . Normally, C fibers faithfully 311 encode the intensity of mechanical stimuli by firing action potentials in direct relation to the 312 stimulus intensity (Stucky et al., 1999) . However, C fibers from diabetic animals failed to encode 313 the intensity of the stimulus as they responded weakly to mechanical stimuli, especially at high 314 intensity forces. Interestingly, other subtypes of neurons with slowly adapting response 315 properties were essentially normal in diabetic mice. For example, AM nociceptors and Slowly 316
Adapting Aβ fibers were essentially normal in their responsiveness to mechanical stimuli (Fig  317   6B,D) . Rapidly Adapting Aβ fibers from diabetic mice also responded significantly less to 318 mechanical force than fibers from nondiabetic mice (p < 0.05, Fig 6C) . In fact, forces above 5 319 mN elicited only half as many action potentials in diabetic nerve fibers. In contrast, the 320 mechanical response properties of rapidly adapting D-hair afferents were unaffected in diabetic 321 animals ( Fig 6E) . Thus, in addition to distal cutaneous denervation, these functional changes in 322 mechanical responsiveness at in the sensory terminal of mechanoreceptors would further 323 contribute to the hypoalgesia observed in diabetic C57Bl/6 mice. 324 325 C fibers exhibit an increased threshold to heat stimuli in diabetic mice 326
As diabetic mice exhibit significantly delayed behavioral responses to heat, we also 327 examined the response of C fibers to heat stimuli. Characterized C fibers were superfused with 328 heated buffer, warming the receptive field from 32 to 52°C over 10 sec. We found no difference 329 in the proportion of C fibers that respond to the heat ramp (54% of nondiabetic vs. 61% of 330 diabetic C fibers; p = 0.39; Fig 7A) . Also, the heat stimulus evoked similar numbers of action 331 potentials from heat-sensitive C fibers in nondiabetic and diabetic mice (mean of 35 vs. 29 action 332 potentials, respectively; p = 0.55; Fig 7B) . However, C fibers from diabetic mice exhibited 333 significantly elevated heat response thresholds compared to nondiabetic mice (median 41.3 vs. 334 37.1°C, respectively; p < 0.05; Fig 7C) . Some AM fibers are sensitive to heat stimuli and 335 contribute to behavioral heat responses. However, we did not record from enough heat-sensitive 336 AM fibers to compare heat responses between diabetic and nondiabetic animals (n = 2 for 337 nondiabetic and n = 3 for diabetic mice). Thus, diabetes increases the threshold at which C fibers 338 respond to heat stimuli. However, the proportion of heat-sensitive C fibers and the magnitude of 339 responses to heat stimuli were unaffected. 340
Following the heat stimuli, C fibers were exposed to the TRPV1 agonist, capsaicin. 341 TRPV1 is sensitive to temperatures above 43°C and is important for normal behavioral 342 responses to heat stimuli. As with heat responses, similar proportions of C fibers responded to 343 capsaicin in nondiabetic and diabetic animals (62% vs. 61%, respectively; Fig 7D) . Further, the 344 number of action potentials elicited by capsaicin was similar between nondiabetic and diabetic 345 animals (median 41 vs 39 action potentials, respectively; Fig 7E) . These data suggest that neither 346 TRPV1 expression or function are altered considerably in diabetic mice. 347
348
Nerve fiber conduction velocity is maintained in diabetic mice 349
The in vitro skin-nerve preparation allowed the assessment of conduction velocities in 350 individual sensory nerve axons. Here, the conduction velocities of subtypes of sensory nerve 351 fibers in diabetic and nondiabetic animals were quantified. No significant changes in conduction 352 velocity were evident among the various subtypes of sensory nerve fibers in diabetic animals 353 (Table 2) . It is plausible to suggest that no differences were observed because conduction 354 velocity itself was one of the parameters used to classify nerve fibers and thus slow-conducting 355 fibers may have been misclassified as a different fiber subtype. While this is possible, we 356 observed no examples of oddly-characterized fibers. For instance, we observed no "D hairs with 357 abnormally small receptive fields" that could be slow-conducting Rapidly Adapting Aβ fibers. 358
Of note, an overall decrease in conduction velocity would have been reported in diabetic mice if 359 sensory nerve fibers had not been classified into subtypes. This resulted from the loss of 360 functional Aβ fibers in diabetic skin nerve preparations. 361
Discussion 363
The goal of this study was to identify the effects of diabetes on peripheral nerves of 364 diabetic C57Bl/6 mice in the setting of insensate neuropathy. Behavioral, histological and 365 electrophysiological approaches revealed marked morphological and functional changes in 366 peripheral nerve fibers 6-8 weeks following induction of diabetes. Notably, the mechanical 367 responses of C fibers and rapidly adapting Aβ light touch mechanoreceptors were markedly 368 impaired in diabetic mice. 369
Our electrophysiological results provide novel insight into the function of sensory nerve 370 fibers in mice with diabetic neuropathy. Unmyelinated C fibers from diabetic mice responded 371 poorly to mechanical stimuli across a range of forces (40-200 mN) and failed to increase their 372 response to more intense stimuli. Further, heat response thresholds were significantly increased 373 in C fibers from diabetic mice. These results differ from teased fiber recordings in streptozoticin-374 treated rats, in which C fibers exhibit decreased mechanical thresholds and increased 375 responsiveness to suprathreshold stimuli, reflecting sensitization of nociceptors in rat. Of note, 376 these rat recordings were performed at a time point when the animals exhibited behavioral 377 hypersensitivity to mechanical stimuli (Chen and Levine, 2001; Suzuki et. al., 2002) . 378 C fibers normally encode a variety of noxious and innocuous stimuli, encode the stimulus 379 intensity, and play an important role in avoiding tissue injury. C fibers in diabetic mice no longer 380 fulfill this role, at least for mechanical stimuli, as noxious forces elicited similar numbers of 381 action potentials as innocuous forces. Although C fibers in diabetic animals respond to heat with 382 similar numbers of action potentials, the increase in heat response threshold coincides with a 383 clear behavioral hyposensitivity to heat. Interestingly, not all nociceptor-type populations were 384 affected by diabetes as myelinated AM fibers exhibited normal mechanical responsiveness in 385 diabetic animals. Nonetheless, C fibers account for 60-75% of all axons in peripheral cutaneous 386 nerves and many C fibers summate on second-order spinal cord neurons. Therefore, the deficit in 387 C fiber function could greatly affect detection of acute noxious and innocuous force (Griffin et 388 al., 2001) . 389
Diabetes also reduced the mechanical firing of rapidly adapting Aβ fibers. Rapidly 390
Adapting Aβ fibers are light touch mechanoreceptors that innervate guard hair follicles in hairy 391 skin and Meissner corpuscles in glabrous skin. The exquisite sensitivity of Rapidly Adapting Aβ 392 fibers to dynamic stimuli greatly enhances our perception of object texture and edges. Thus, 393 deficits in Rapidly Adapting Aβ function could lead to a considerable loss of normal tactile 394 acuity in diabetic animals. 395
Significant changes to the structure of distal myelinated nerve fibers occurred in diabetic 396 mice. Myelinated axons contained numerous organelles, possibly reflecting impaired transport 397 along nerve fibers or an increase in the number of mitochondira within the axoplasm. Also, 398 myelinated axons were frequently separated from their myelin sheath. These separations did not 399 appear to result from axonal atrophy, as axons from diabetic mice were not significantly smaller 400 than axons from nondiabetic mice ( Supplemental Fig 1) . Several scorpion venom toxins have 401 been shown to induce periaxonal edema, presumably due to an osmotic imbalance due to sodium 402 channel dysfunction (Love et al., 1986) . Further, high plasma mannitol concentrations produce a 403 hyperosmolar perineurial environment, increase the amount of glycogen present in Schwann 404 cells and lead to axon-myelin separation in rat studies (Myers and Powell, 1983; Myers and 405 Powell, 1984) . Thus, axon-myelin separations in diabetic mouse axons may reflect an osmotic 406 imbalance due to hyperglycemia, accumulation of glycogen in the Schwann cell, or secondarily, 407 membrane channel dysfunction in diabetic mice. Separations between the axon and myelin 408 sheath could also reflect axoglial disjunction in the paranodal region of diabetic nerve fibers, as 409 previously described in diabetic rats (Sima et al., 1986) . Importantly, changes in plasma 410 osmolarity due to elevated glucose concentration have been demonstrated to directly affect 411 sensory nerve fiber function in diabetic rats (Suzuki et. al., 2002) . 412
Morphological analyses highlighted two important features of neuropathy in 413 streptozotocin-treated mice. First, axon-myelin separations were restricted to distal nerve 414 segments nearing their innervation territory in the skin of diabetic mice. This pattern is consistent 415 with the pattern of peripheral neuropathy observed in human diabetic patients where the distal 416 aspects of long peripheral nerve fibers are affected first and most severely. Second, the axon-417 myelin separations were significantly more common among large-caliber axons in diabetic mice. 418
This finding suggests that Aβ fiber axons are most susceptible to damage after 6-8 weeks of 419 diabetes and supports electrophysiological data that demonstrates a preferential loss of functional 420
Aβ fiber innervation in the skin. 421
Morphological changes coincided with a shift in the relative abundance of functional 422 cutaneous nerve fibers. A lesser proportion of heavily myelinated Aβ fibers was encountered in 423 diabetic skin-nerve preparations than in control preparations. However, there was no change in 424 the proportion of rapidly adapting versus slowly adapting subtypes among either the Aβ or Aδ 425 fibers. Thus, diabetes equally affected both Rapidly Adapting Aβ fibers that predominately 426 innervate hair follicles (in hairy skin) or Meissner corpuscles (in glabrous skin) and Slowly 427
Adapting Aβ fibers that terminate either on Merkel cells (SAI) or as free nerve endings (SAII) at 428 the dermal-epidermal border (Lumpkin and Caterina, 2007; Maricich et al., 2009) . Previous 429 studies have reported losses of both myelinated and unmyelinated nerve fibers in diabetic skin. 430
Although conduction abnormalities have been described in human diabetics and in 431 animal models of diabetes, we did not observe significant changes to the conduction velocity of 432 diabetic nerve fibers in mice. Human and rat studies report nerve conduction slowing after 433 several months to several years of diabetes and in the context of severe nerve fiber pathology 434 (Sima et al., 1982) . In contrast, we observe only modest nerve fiber pathology after a relatively 435 short (6-8 week) duration of diabetes. In particular, there was no evidence of demyelination in 436 diabetic mice. Thus, the absence of conduction velocity abnormalities may reflect the absence of 437 segmental demyelination and remyelination in diabetic mice during the initial eight weeks of 438 diabetes. A longer time course of diabetes may be necessary for diabetic mice to develop 439 pronounced nerve fiber pathology and to observe a change in nerve fiber conduction velocity. 440
In summary, diabetes impaired the function of sensory nerve fibers and reduced the 441 abundance of functional Aβ fibers in diabetic skin, resulting in behavioral hyposensitivity to 442 mechanical and heat stimuli. Histological analyses revealed changes that were restricted to distal 443 segments of diabetic nerve fibers. Presumably, these represent early pathological changes 444 associated with murine diabetes. Thus, diabetic mice develop a peripheral, insensate neuropathy 445 that shares physiological and anatomical similarities with insensate diabetic neuropathy in 446 humans. Importantly, our findings suggest that the sensory losses experienced by human diabetic 447 patients may be due to impaired nerve fiber function as well as sensory denervation. Frey threshold and interquartile range for nerve fiber subtypes in diabetic and nondiabetic mice. 642
Subtypes were compared using Wilcoxon rank sum tests. 643 644 Table 2 . Sensory nerve fiber conduction velocity is unaffected in diabetic mice. Average 645 conduction velocity for nerve fiber subtypes in diabetic and nondiabetic mice. Subtypes were 646 compared using Student's t-tests. 647
